1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global - Cancer Vaccines Market and Pipeline Vaccines Analysis to 2020

Global - Cancer Vaccines Market and Pipeline Vaccines Analysis to 2020

  • November 2015
  • 213 pages
  • ID: 3397896


Table of Contents

Search Inside

The cancer industry is one of the most lucrative business worldwide. Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. Cancer vaccines can be broadly classified into two segments: prophylactic and therapeutic vaccines. Prophylactic vaccines are used for the prevention of cancer, whereas therapeutic vaccines are used for treatment of cancer. With the rising incidences of cancer and limited treatment options, physicians are being forced to look for precautionary vaccines beyond the conventional treatments. As a result, many companies are now investing in developing prophylactic and therapeutic vaccines to curb this deadly disease.

The prophylactic vaccines currently available in the market include Mercks Gardasil and GSKs Cervarix while the only therapeutic vaccine in the market is Dendreon's Provenge. In the global cancer vaccines market, the prophylactic vaccines segment account for maximum share of the market. However, the market share of prophylactic vaccines is likely to decline continuously during the forecasting period due to the increasing uptake of therapeutic vaccines. The market share of therapeutic cancer vaccines is anticipated to increase during the forecasting period.

In the cancer vaccines market, Merck is the clear leader and is expected to maintain its dominancy over a longer period of time. Dendreon Corporation is the second leading player in cancer vaccines market accounting for XX% market share in 2014. It is predicted that GSK will account for single digit share of the cancer vaccine market by 2020.

Global Cancer Vaccines Market - Regional Analysis: The United States is the largest regional market for cancer vaccines. United States accounted for XX% share of the global cancer vaccines market in 2014. The Asian region is the second leading market for cancer vaccines. The European region cancer vaccines market share is anticipated to increase from XX% in 2014 to XX% by the year 2020.

iGATE Research report titled Global - Cancer Vaccines Market and Pipeline Vaccines Analysis to 2020 is a 213 page report with 26 Figures and 25 Tables. This report studies in detail the Global Cancer Vaccines Market, Regional Cancer Vaccines Market, Major Deals and Funding in Cancer Vaccines Industry, Cancer Vaccines Pipeline Products Portfolio, Company Wise Cancer Vaccines Pipeline Products and the driving factors and challenges for the Cancer Vaccines Market.

The Cancer Vaccines Market studied in the report covers the following 7 points:

1. Global - Prophylactic Cancer Vaccines Market to 2020

I. Gardasil
II. Cervarix

2. Global - Therapeutic Cancer Vaccines Market to 2020

I. Provenge

3. Cancer Vaccines Market - Regional Analysis to 2020

I. United States - Cancer Vaccines Market
II. Europe - Cancer Vaccines Market
III. Asia - Cancer Vaccines Market

4. Global Cancer Vaccines Market - Major Deals
5. Global Cancer Vaccines - Funding
6. Global Cancer Vaccines Market - Pipeline Portfolio Analysis
7. Company Cancer Vaccines - Pipeline Analysis

The 12 Cancer Vaccines Pipeline Portfolio covered in the report are as follows

1. Prostvac
2. Neuvax
3. Rindopepimut
4. MVax
5. DCVax-L
6. ProstAtak
7. Talimogene Laherparepvec
8. IMA901
9. Imprime PGG
10. OncoVAX
11. Lucanix

The 34 Companies Pipeline Cancer Vaccines covered in the reports are as follows:

1. Aduro Biotech
2. Advantagene
3. Advaxis
4. Agenus
5. AlphaVax
6. Altor BioScience
7. Argos Therapeutics
8. AVAX Technologies
9. Bavarian Nordic
10. Biothera
11. Celldex Therapeutics
12. CureVac
13. Galena Biopharma
14. Genexine
15. GlobeImmune
16. Gradalis
17. Heat Biologics
18. Immatics
19. ImmunoCellular Therapeutics
20. Inovio Pharmaceuticals
21. ISA Pharmaceuticals
22. Juvaris Biotherapeutics
23. NewLink Genetics
24. Northwest Biotherapeutics
25. NovaRx
26. OncoThyreon
27. Oncovir
28. Oxford BioMedica
29. Prima BioMed
30. Sotio
31. Transgene
32. Ubivac
33. Vaccinogen
34. Vaxon Biotech

Source of Information

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government And NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries And Local Councils and a large number of Paid Databases.

Please note: this report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H2 2018

Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H2 2018

  • $ 3500
  • November 2018

Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H2 2018SummaryAccording to the recently published report ’Wilms Tumor Protein - Pipeline Review, H2 2018’; Wilms Tumor Protein (WT33 or WT1) pipeline ...

Measles - Pipeline Review, H2 2018

Measles - Pipeline Review, H2 2018

  • $ 2000
  • October 2018

Measles - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Measles - Pipeline Review, H2 2018, provides an overview of the Measles (Infectious ...

Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2018

Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2018

  • $ 2000
  • September 2018

Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Epstein-Barr Virus (HHV-4) Infections - Pipeline ...


Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on